These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27876107)

  • 1. Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation.
    Jin CJ; Engstler AJ; Sellmann C; Ziegenhardt D; Landmann M; Kanuri G; Lounis H; Schröder M; Vetter W; Bergheim I
    Br J Nutr; 2016 Nov; 116(10):1682-1693. PubMed ID: 27876107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
    Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
    Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
    Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
    Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
    Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
    Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.
    Jin CJ; Engstler AJ; Ziegenhardt D; Bischoff SC; Trautwein C; Bergheim I
    J Gastroenterol Hepatol; 2017 Mar; 32(3):708-715. PubMed ID: 27404046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
    Baumann A; Burger K; Brandt A; Staltner R; Jung F; Rajcic D; Lorenzo Pisarello MJ; Bergheim I
    Metabolism; 2022 Aug; 133():155233. PubMed ID: 35654114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
    Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.
    Jung F; Lippmann T; Brandt A; Jin CJ; Engstler AJ; Baumann A
    Eur J Nutr; 2020 Mar; 59(2):787-799. PubMed ID: 30879098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
    Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
    Ritze Y; Bárdos G; Claus A; Ehrmann V; Bergheim I; Schwiertz A; Bischoff SC
    PLoS One; 2014; 9(1):e80169. PubMed ID: 24475018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
    Wagnerberger S; Spruss A; Kanuri G; Volynets V; Stahl C; Bischoff SC; Bergheim I
    Br J Nutr; 2012 Jun; 107(12):1727-38. PubMed ID: 22018861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
    Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides.
    Beisner J; Filipe Rosa L; Kaden-Volynets V; Stolzer I; Günther C; Bischoff SC
    Front Immunol; 2021; 12():678360. PubMed ID: 34177920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
    Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
    Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
    Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
    J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.
    Brandt A; Rajcic D; Jin CJ; Sánchez V; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
    Metabolism; 2020 Aug; 109():154283. PubMed ID: 32497536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels.
    Ye J; Lv L; Wu W; Li Y; Shi D; Fang D; Guo F; Jiang H; Yan R; Ye W; Li L
    Front Microbiol; 2018; 9():1967. PubMed ID: 30186272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
    Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I
    Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
    Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
    Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.
    Spruss A; Kanuri G; Uebel K; Bischoff SC; Bergheim I
    Antioxid Redox Signal; 2011 Jun; 14(11):2121-35. PubMed ID: 21083420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.